Traditional drug discovery finds “hit” candidates and then tries to turn them into drugs. DenovAI’s “one-shot” approach asks a different question: what if you designed the drug all in one go? “This is really a priori design… trying to build it all in from the get-go. I believe we’re on the verge of cracking this,”…
